Radius Health is betting the promise of its bone-boosting drug will sway investors to buy into its planned $92 million IPO, forging ahead in what has become a shaky market for biotech debuts.

…read more

Source: Radius dials up a $92M IPO pitch despite tepid market for biotechs


0 No comments